Sun Pharmaceutical Industries, Inc. Issues Voluntary Nationwide Recall of Vecuronium Bromide for Injection Due to the Presence of Particulate Matter Identified as Glass

Tuesday, January 8, 2019 Drug News
Email Print This Page Comment bookmark
Font : A-A+

PRINCETON, New Jersey, January 8, 2019 /PRNewswire/ --

Sun Pharmaceutical Industries, Inc. (SPII), a wholly owned

subsidiary of Sun Pharmaceutical Industries, Ltd. is voluntarily recalling three lots of Vecuronium Bromide for Injection, 10 mg (lyophilized powder), and one lot of Vecuronium Bromide for Injection, 20 mg (lyophilized powder) to the hospital level.
The Vecuronium Bromide for Injection has been found to contain particulate matter identified as glass.

The administration of a glass particulate, if present in an intravenous drug, may result in local irritation or swelling in response to the foreign material. More serious potential outcomes would include blockage and clotting in blood vessels, which may be life-threatening. To date, SPII has not received any reports of adverse events related to this recall.

Vecuronium Bromide for Injection is used as an adjunct to general anesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation and is packaged in a glass vial; ten vials per carton. Vecuronium Bromide for Injection should be administered by or under the supervision of experienced clinicians and must be reconstituted prior to use. The affected Vecuronium Bromide for Injection, include the following:

Product Name:    Vecuronium Bromide for Injection, 20 mg Lot Number:      JKS0400A NDC Number:      47335-932-44 [carton]                  47335-932-40 [vial] Expiration Date: 03/2019 Number of Units: 1384 cartons

Product Name:    Vecuronium Bromide for Injection, 10 mg Lot Number:      JKS0443A NDC Number:      47335-931-44 [carton]                  47335-931-40 [vial] Expiration Date: 03/2019 Number of Units: 4404 cartons

Product Name:    Vecuronium Bromide for Injection, 10 mg Lot Number:      JKS0444A NDC Number:      47335-931-44 [carton]                  47335-931-40 [vial] Expiration Date: 03/2019 Number of Units: 3744 cartons    Product Name:    Vecuronium Bromide for Injection, 10 mg Lot Number:      JKS0477A NDC Number:      47335-931-44 [carton]                  47335-931-40 [vial] Expiration Date: 03/2019 Number of Units: 4386 cartons

The product can be identified by vial or carton labeled as Vecuronium Bromide for Injection containing the specific Lot Number and Expiration Dates mentioned above.

This product was distributed nationwide to wholesale customers and medical facilities.

On January 3, 2019, SPII notified its distributors and customers through its 3rd party, Recall Coordinator (Inmar Inc.), via FedEx standard overnight shipping and has arranged for return via prepaid FedEx Ground shipping of all recalled products.

Distributors and medical facilities that have Vecuronium Bromide for Injection, which is being recalled, should stop using and return it to place of purchase or as directed in the recall notification.

Consumers with questions regarding this recall can contact SPII by calling 1-800-406-7984 Monday through Friday between 8:00 am to 5:00 pm EST or e-mailing drug.safetyUSA@sunpharma.com.

Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.            

  • Complete and submit the report Online: www.fda.gov/medwatch/report.htm
  • Regular Mail or Fax: Download form www.fda.gov/MedWatch/getforms.htm or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

Company Contacts:

Consumers Drug.safetyUSA@sunpharma.com   1-800-406-7984    

Media Gaurav Chugh gaurav.chugh@sunpharma.com +91-22-4324-4324 x 5373

SOURCE Sun Pharmaceutical Industries, Inc.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store